A Phase 3, Open-Label, Multisite, Randomized, Parallel Group Study of the Efficacy and Safety of Fixed Combination Torcetrapib/Atorvastatin Administered Once Daily (QD) Compared to Simvastatin for 6 Weeks in Subjects With Hypercholesterolemia (A5091031).

Trial Profile

A Phase 3, Open-Label, Multisite, Randomized, Parallel Group Study of the Efficacy and Safety of Fixed Combination Torcetrapib/Atorvastatin Administered Once Daily (QD) Compared to Simvastatin for 6 Weeks in Subjects With Hypercholesterolemia (A5091031).

Discontinued
Phase of Trial: Phase III

Latest Information Update: 16 Feb 2012

At a glance

  • Drugs Simvastatin; Torcetrapib/atorvastatin
  • Indications Hypercholesterolaemia
  • Focus Biomarker; Registrational; Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 16 Feb 2012 Planned end date 1 Dec 2006 added as reported by ClinicalTrials.gov record.
    • 05 Dec 2006 Status change
    • 18 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top